Catalog No.:AA01FNYB

960404-86-8 | Dapagliflozin Impurity 10

Name: Name:Dapagliflozin Impurity 10
Brand: AABLOCKS
SKU: AA01FNYB
Availability: InStock
Rating: 90 (10 reviews)

Pack Size

Purity

Availability

Price(USD)

Quantity

5mg

99%

1 week

$289.00 $202.00

- +

50mg

98%

1 week

$393.00 $275.00

- +

100mg

98%

1 week

$628.00 $440.00

- +

250mg

98%

1 week

$1,065.00 $746.00

- +

98%

1 week

$2,869.00 $2,008.00

- +

Technical Information
Properties
Downstream Synthesis Route
Literature
Request for Quotation
Download SDS

Technical Information
Properties
Downstream Synthesis Route
Literature

Technical Information

Catalog Number:

AA01FNYB

Chemical Name:

Dapagliflozin Impurity 10

CAS Number:

960404-86-8

Molecular Formula:

C21H25ClO7

Molecular Weight:

424.8720

MDL Number:

MFCD32215328

SMILES:

CCOc1ccc(cc1)Cc1cc(ccc1Cl)[C@]1(O)O[C@H](CO)[C@H]([C@@H]([C@H]1O)O)O

Properties

Computed Properties

Complexity:

515

Covalently-Bonded Unit Count:

Defined Atom Stereocenter Count:

Heavy Atom Count:

Hydrogen Bond Acceptor Count:

Hydrogen Bond Donor Count:

Rotatable Bond Count:

Undefined Atom Stereocenter Count:

XLogP3:

1.6

Downstream Synthesis Route

1103738-29-9

32469-28-6

960404-86-8

[1]Patent:US2013/267694,2013,A1.Locationinpatent:Page/Pagecolumn0338-0346

1103738-29-9

32469-28-6

960404-86-8

C21H27ClO7

[1]Patent:US2013/267694,2013,A1.Locationinpatent:Page/Pagecolumn0321-0329

67-56-1

960404-86-8

714269-57-5

[1]Patent:US2013/267694,2013,A1.Locationinpatent:Paragraph0330-0332

[2]Patent:WO2017/221211,2017,A1.Locationinpatent:Page/Pagecolumn17-18

461432-23-5

(3R,4S,5R,6R)-3,4,5-tris((trimethylsilyl)oxy)-6-(((trimethylsilyl)oxy)methyl)tetrahydro-2H-pyran-2-one

960404-86-8

[1]CurrentPatentAssignee:BIOCONLIMITED-WO2017/221211,2017,A1Locationinpatent:Page/Pagecolumn17

960404-86-8

461432-26-8

[1]CurrentPatentAssignee:ZHEJIANGMENOVOPHARMACEUTICALS-CN113979978,2022,A

Literature

Title: Kasichayanula S, et al. Lack of pharmacokinetic interaction between dapagliflozin, a novel sodium-glucose transporter 2 inhibitor, and metformin, pioglitazone, glimepiride or sitagliptin in healthy subjects. Diabetes Obes Metab. 2011 Jan;13(1):47-54.

Quotation Request

Company Name:

Contact Person:

Email:

Quantity Required:

Country: